Name | 1,1-dioxo-2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,2-benzothiazol-3-one |
---|---|
Synonyms |
ABT 702 dihydrochloride
Ipsapironum IPSAPIRONE Ipsapirona |
Description | Ipsapirone (TVX Q 7821), an anxiolytic compound and a 5-HT1A partial agonist, also exhibits 5-HT1A antagonistic effect, and only at high doses it can also produce an inhibitory effect on 5-HT2 and the α1-adrenergic function[1][2]. |
---|---|
Related Catalog | |
Target |
5-HT1A Receptor |
In Vivo | Ipsapirone inhibits induced by 8-OH-DPAT and 5-methoxydimethyltryptamine (agonists of 5-HT1A receptors) behavioural effects (flat body posture and forepaw treading) in normal and reserpinized rats[1]. Ipsapirone (2.5-80 mg/kg), given alone to rats induces a slight flattening of body posture (~ 1 point at the highest dose) and a mild hind limb abduction observed at doses 2.5-80 mg/kg. Ipsapirone given alone at low doses (2.5-10 mg/kg i.p.) does not significantly change the body temperature in rats and mice, but decreased it in both those species at high doses (35 mg/kg i.p.) by ca. 2-2.5℃[1]. Animal Model: Male Albino-Swiss mice (18-24 g) and male Wistar rats (160-200 g)[1]. Dosage: 5 and 10 mg/kg. Administration: IP 30 min before 8-OH-DPAT and 5-MeODMT injections. Result: Behavioural responses (flat body posture, forepaw treading) to 8-OH-DPAT (5 mg/kg s.c.) in rats were antagonized by Ipsapirone (5 and 10 mg/kg i.p.). |
References |
Density | 1.345g/cm3 |
---|---|
Boiling Point | 629.8ºC at 760mmHg |
Molecular Formula | C19H23N5O3S |
Molecular Weight | 401.48300 |
Flash Point | 334.7ºC |
Exact Mass | 401.15200 |
PSA | 95.09000 |
LogP | 2.24510 |
Index of Refraction | 1.622 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|